Nuveen Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-605,780
| Closed | -$1.91M | – | 3355 |
|
|
2020
Q3 | $1.91M | Buy |
605,780
+96,263
| +19% | +$303K | ﹤0.01% | 2406 |
|
|
2020
Q2 | $1.48M | Buy |
509,517
+798
| +0.2% | +$2.32K | ﹤0.01% | 2460 |
|
|
2020
Q1 | $1.44M | Sell |
508,719
-15,938
| -3% | -$45K | ﹤0.01% | 2350 |
|
|
2019
Q4 | $1.7M | Sell |
524,657
-1,647
| -0.3% | -$5.35K | ﹤0.01% | 2488 |
|
|
2019
Q3 | $1.14M | Sell |
526,304
-26,729
| -5% | -$57.7K | ﹤0.01% | 2645 |
|
|
2019
Q2 | $1.74M | Buy |
+553,033
| New | +$1.74M | ﹤0.01% | 2498 |
|
|
2017
Q1 | – | Sell |
-10,342
| Closed | -$22K | – | 1552 |
|
|
2016
Q4 | $22K | Sell |
10,342
-271
| -3% | -$576 | ﹤0.01% | 1468 |
|
|
2016
Q3 | $36K | Hold |
10,613
| – | – | ﹤0.01% | 1333 |
|
|
2016
Q2 | $33K | Sell |
10,613
-503
| -5% | -$1.56K | ﹤0.01% | 1260 |
|
|
2016
Q1 | $37 | Sell |
11,116
-550
| -5% | -$2 | ﹤0.01% | 1342 |
|
|
2015
Q4 | $41 | Sell |
11,666
-789
| -6% | -$3 | ﹤0.01% | 1394 |
|
|
2015
Q3 | $63 | Hold |
12,455
| – | – | ﹤0.01% | 1409 |
|
|
2015
Q2 | $80 | Hold |
12,455
| – | – | ﹤0.01% | 1452 |
|
|
2015
Q1 | $88K | Sell |
12,455
-10,546
| -46% | -$74.5K | ﹤0.01% | 1465 |
|
|
2014
Q4 | $177K | Buy |
23,001
+10,047
| +78% | +$77.3K | ﹤0.01% | 1471 |
|
|
2014
Q3 | $97K | Hold |
12,954
| – | – | ﹤0.01% | 1466 |
|
|
2014
Q2 | $125K | Sell |
12,954
-370
| -3% | -$3.57K | ﹤0.01% | 1486 |
|
|
2014
Q1 | $111K | Buy |
13,324
+1,658
| +14% | +$13.8K | ﹤0.01% | 1485 |
|
|
2013
Q4 | $98K | Buy |
11,666
+844
| +8% | +$7.09K | ﹤0.01% | 1448 |
|
|
2013
Q3 | $86K | Buy |
10,822
+736
| +7% | +$5.85K | ﹤0.01% | 1351 |
|
|
2013
Q2 | $78K | Buy |
+10,086
| New | +$78K | ﹤0.01% | 1427 |
|